GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Other Operating Expense

Takara Bio (TSE:4974) Other Operating Expense : 円15,580 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Other Operating Expense?

Takara Bio's Other Operating Expense for the three months ended in Mar. 2024 was 円3,998 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円15,580 Mil.

Takara Bio's quarterly Other Operating Expense increased from Sep. 2023 (円3,863 Mil) to Dec. 2023 (円3,892 Mil) and increased from Dec. 2023 (円3,892 Mil) to Mar. 2024 (円3,998 Mil).

Takara Bio's annual Other Operating Expense increased from Mar. 2022 (円14,198 Mil) to Mar. 2023 (円15,644 Mil) but then declined from Mar. 2023 (円15,644 Mil) to Mar. 2024 (円15,580 Mil).


Takara Bio Other Operating Expense Historical Data

The historical data trend for Takara Bio's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Other Operating Expense Chart

Takara Bio Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,958.00 12,372.00 14,198.00 15,644.00 15,580.00

Takara Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,482.00 3,827.00 3,863.00 3,892.00 3,998.00

Takara Bio Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円15,580 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takara Bio Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Takara Bio's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Takara Bio (TSE:4974) Business Description

Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines